Company Filing History:
Years Active: 1987
Title: The Innovations of Howard E. Gracey
Introduction
Howard E. Gracey is a notable inventor based in Lindenhurst, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on erythromycin derivatives. His innovative approach has led to advancements in antimicrobial treatments.
Latest Patents
One of Howard E. Gracey's key patents is for the invention titled "Erythromycin A 11,12-carbonate and method of use." This patent describes an erythromycin A derivative that exhibits high antimicrobial activity and improved pharmacokinetics. The 4'-Deoxyerythromycin A 11,12-carbonate and its derivatives demonstrate superior in vitro and in vivo antimicrobial activity compared to erythromycin A. Additionally, when administered to animals, this derivative has a serum half-life that is significantly prolonged over that of erythromycin A.
Career Highlights
Howard E. Gracey is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing innovative solutions that address critical health challenges. With a total of 1 patent, his contributions are recognized within the industry.
Collaborations
Throughout his career, Howard has collaborated with esteemed colleagues, including Leslie A. Freiberg and Andre G. Pernet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Howard E. Gracey exemplifies the spirit of innovation in the pharmaceutical industry. His work on erythromycin derivatives has the potential to significantly impact antimicrobial treatments. His contributions continue to inspire future advancements in healthcare.